{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T16:28:13Z","timestamp":1786811293367,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,15]]},"DOI":"10.7759\/cureus.114569","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T15:51:13Z","timestamp":1786809073000},"source":"Crossref","is-referenced-by-count":0,"title":["Investigating the Association Between Semaglutide Use and Mood Disorders in Polyendocrine Metabolic Ovarian Syndrome: A Retrospective Cohort Study\u200b"],"prefix":"10.7759","author":[{"given":"Freida  P","family":"Raj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Boo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Kenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Espiridion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2025.101203","article-title":"The overlooked mental health burden of polycystic ovary syndrome: neurobiological insights into PCOS-related depression","volume":"78","author":"Dub\u00e9-Zinatelli E","year":"2025","unstructured":"Dub\u00e9-Zinatelli E, Anderson F, Ismail N. The overlooked mental health burden of polycystic ovary syndrome: neurobiological insights into PCOS-related depression. Front Neuroendocrinol. 2025, 78:101203. 10.1016\/j.yfrne.2025.101203","journal-title":"Front Neuroendocrinol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12206446","article-title":"Depression in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"12","author":"Dybciak P","year":"2023","unstructured":"Dybciak P, Raczkiewicz D, Humeniuk E, et al.. Depression in polycystic ovary syndrome: a systematic review and meta-analysis. J Clin Med. 2023, 12:10.3390\/jcm12206446","journal-title":"J Clin Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.957112","article-title":"A meta-analysis of the relationship between polycystic ovary syndrome and sleep disturbances risk","volume":"13","author":"Wang C","year":"2022","unstructured":"Wang C, Huang T, Song W, et al.. A meta-analysis of the relationship between polycystic ovary syndrome and sleep disturbances risk. Front Physiol. 2022, 13:957112. 10.3389\/fphys.2022.957112","journal-title":"Front Physiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede HJ","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, et al.. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018, 33:1602-18. 10.1093\/humrep\/dey256","journal-title":"Hum Reprod"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002656","article-title":"ACOG practice bulletin no. 194: Polycystic ovary syndrome","volume":"131","year":"2018","unstructured":"ACOG practice bulletin no. 194. Polycystic ovary syndrome. Obstet Gynecol. 2018, 131:e157-71. 10.1097\/AOG.0000000000002656","journal-title":"Obstet Gynecol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7421.951","article-title":"Metformin in polycystic ovary syndrome: systematic review and meta-analysis","volume":"327","author":"Lord JM","year":"2003","unstructured":"Lord JM, Flight IH, Norman RJ. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ. 2003, 327:951-3. 10.1136\/bmj.327.7421.951","journal-title":"BMJ"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ph18030399","article-title":"Semaglutide as a GLP-1 agonist: a breakthrough in obesity treatment","volume":"18","author":"Salvador R","year":"2025","unstructured":"Salvador R, Moutinho CG, Sousa C, Vinha AF, Carvalho M, Matos C. Semaglutide as a GLP-1 agonist: a breakthrough in obesity treatment. Pharmaceuticals (Basel). 2025, 18:10.3390\/ph18030399","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2024.108834","article-title":"The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: a meta-analysis of randomized controlled trials","volume":"38","author":"Austreg\u00e9silo de Athayde De Hollanda Morais B","year":"2024","unstructured":"Austreg\u00e9silo de Athayde De Hollanda Morais B, Martins Priz\u00e3o V, de Moura de Souza M, Ximenes Mendes B, Rodrigues Defante ML, Cosendey Martins O, Rodrigues AM. The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: a meta-analysis of randomized controlled trials. J Diabetes Complications. 2024, 38:108834. 10.1016\/j.jdiacomp.2024.108834","journal-title":"J Diabetes Complications"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13111503","article-title":"GLP-1 receptor agonists and related mental health issues; Insights from a range of social media platforms using a mixed-methods approach","volume":"13","author":"Arillotta D","year":"2023","unstructured":"Arillotta D, Floresta G, Guirguis A, et al.. GLP-1 receptor agonists and related mental health issues; Insights from a range of social media platforms using a mixed-methods approach. Brain Sci. 2023, 13:10.3390\/brainsci13111503","journal-title":"Brain Sci"},{"key":"ref10","unstructured":"TriNetX LLC. (2025). https.\/\/trinetx.com\/."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/20565623.2025.2483607","article-title":"The multifaceted effects of semaglutide: exploring its broad therapeutic\u00a0applications","volume":"11","author":"Alkhatib M","year":"2025","unstructured":"Alkhatib M, Almasri N, Alshwayyat S, et al.. The multifaceted effects of semaglutide: exploring its broad therapeutic\u00a0applications. Future Sci OA. 2025, 11:2483607. 10.1080\/20565623.2025.2483607","journal-title":"Future Sci OA"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2008.09.008","article-title":"Associations of obesity with psychiatric disorders and suicidal behaviors in a nationally representative sample","volume":"66","author":"Mather AA","year":"2009","unstructured":"Mather AA, Cox BJ, Enns MW, Sareen J. Associations of obesity with psychiatric disorders and suicidal behaviors in a nationally representative sample. J Psychosom Res. 2009, 66:277-85. 10.1016\/j.jpsychores.2008.09.008","journal-title":"J Psychosom Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.37765\/ajmc.2025.89778","article-title":"Trends in glucagon-like peptide 1 receptor agonist prescribing patterns","volume":"31","author":"Ukhanova M","year":"2025","unstructured":"Ukhanova M, Wozny JS, Truong CN, Ghosh L, Krause TM. Trends in glucagon-like peptide 1 receptor agonist prescribing patterns. Am J Manag Care. 2025, 31:e228-34. 10.37765\/ajmc.2025.89778","journal-title":"Am J Manag Care"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02672-2","article-title":"Association of semaglutide with risk of suicidal ideation in a real-world cohort","volume":"30","author":"Wang W","year":"2024","unstructured":"Wang W, Volkow ND, Berger NA, Davis PB, Kaelber DC, Xu R. Association of semaglutide with risk of suicidal ideation in a real-world cohort. Nat Med. 2024, 30:168-76. 10.1038\/s41591-023-02672-2","journal-title":"Nat Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000046173","article-title":"Assessing the shadows: a meta-analysis of GLP-1 agonists and suicidal ideation","volume":"104","author":"Alansari AO","year":"2025","unstructured":"Alansari AO, Alharbi AS, Alshehri KM, et al.. Assessing the shadows: a meta-analysis of GLP-1 agonists and suicidal ideation. Medicine (Baltimore). 2025, 104:e46173. 10.1097\/MD.0000000000046173","journal-title":"Medicine (Baltimore)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/524253-investigating-the-association-between-semaglutide-use-and-mood-disorders-in-polyendocrine-metabolic-ovarian-syndrome-a-retrospective-cohort-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T15:51:14Z","timestamp":1786809074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/524253-investigating-the-association-between-semaglutide-use-and-mood-disorders-in-polyendocrine-metabolic-ovarian-syndrome-a-retrospective-cohort-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,15]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.114569","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,15]]}}}